Anti-Human C5 Recombinant Antibody(Eculizumab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human C5 Recombinant Antibody(Eculizumab)

Anti-Human C5 Recombinant Antibody(Eculizumab)

产品编号

YR1003

别名

科研级 Eculizumab ( 依库珠单抗 ), Anti-C5 Recombinant Antibody, Research Grade Eculizumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Eculizumab ( 依库珠单抗 ), Anti-C5 Recombinant Antibody, Research Grade Eculizumab
Catalog Number	YR1003
Molecular Name	Eculizumab
CAS Number	219685-50-4
Molecular Weight	148 kDa
Target	C5[Homo sapiens]
Antibody Isotype	IgG2-G4 Kappa
Clonity	Monoclonal
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Formulation	PBS, pH7.5
Shipping Condition	Shipped on ice packs.
Background	Eculizumab, sold under the brand name Soliris among others, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death.
Application	ELISA, FCM, IP, FuncS, IF, Neut
Remarks	This product is for research use only.

推荐产品

400-621-6806
614353794
周一至周五 8:30-18:00
0